Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

CombiMatrix Corp

+ Add to Watchlist

CBMX:US

3.2200 USD 0.0100 0.31%

As of 20:10:00 ET on 05/24/2013.

Company Profile for CombiMatrix Corp (CBMX)

CombiMatrix Corporation is a biotechnology company. The Company developed technology to produce DNA arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. The technology is used in genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology.

Contact Information

CombiMatrix Corp

300 Goddard
Suite 100
Irvine, CA 92618
United States
Phone: 1-949-753-0624
Fax: 1-949-753-1504

Key Executives for CombiMatrix Corp (CBMX)

Mark McDonoughPresident/CEOScott R BurellCFO/Treasurer/Secretary
Richard D Hockett JrChief Medical Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil